title: Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes?
authors: D L
authors: DL
authors: Monnet
authors: F M
authors: FM
authors: MacKenzie
authors: R
authors: R
authors: Skov
authors: E T
authors: ET
authors: Jensen
authors: I M
authors: IM
authors: Gould
authors: N
authors: N
authors: Frimodt-Møller
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D004363:Drug Utilization; D024841:Fluoroquinolones / Q000627:therapeutic use; D006291:Health Policy; D006801:Humans; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control* / Q000635:transmission; D013211:Staphylococcus aureus / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones